Supplementary Table I. Tapering outcomes among patients with baseline SALT>50

Tapering outcomes and baseline disease severity among patients with severe alopecia areata, defined as a baseline SALT score greater than 50. Data are presented as n (%) or median (IQR). Baseline SALT >50 was defined using the SALT score at baricitinib initiation. Abbreviations: IQR, interquartile range; SALT, Severity of Alopecia Tool.